Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ENGN
ENGENE HOLDINGS INC.
NASDAQ
$1.82
▼ DOWN 4.45% (-0.09)

KEY STATISTICS

Market Cap$122.26 M
52w High$12.25
52w Low$1.40
Dividend Yield3.50%
FrequencyQuarterly
P/E-0.84
Volume447.09K
Shares Out.66.99M

COMPANY

LEADERSHIP

Ronald H. W. Cooper
CHIEF EXECUTIVE
Ronald H. W. Cooper

COMPENSATION 2026

Salary$700,000
Stock Awards$0
Incentive Plan Pay$483,000
All Other Comp.$30,529
Total$5,758,289

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 1, 2022
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
82

PRICE TARGET

Target High$4.00
Target Low$2.00
Target Median$3.00
Target Consensus$3.00

UPCOMING EARNINGS

DateSep 14, 2026
DayMonday
Rev. Est.—
SEP
14
MON

PRICE

$1.82 ▼ DOWN 4.45% (−$0.09)
$1.83$1.85$1.88$1.909:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.82

About enGene Holdings Inc.

https://www.engene.com ↗

enGene Holdings Inc., a clinical-stage biotech founded in 2023 in Canada, develops genetic medicines like its lead non-viral immunotherapy EG-70 to treat bladder cancer patients unresponsive to BCG.

INDUSTRY

Biotechnology

A PRODUCT ENGENE HOLDINGS INC. IS KNOWN FOR

EG-70 (detalimogene voraplasmid)
EG-70 (detalimogene voraplasmid)

EG-70 is enGene's lead non-viral gene therapy for BCG-unresponsive non-muscle invasive bladder cancer, currently in Phase 2 trials and serving as the company's main focus.

COMPETITORS

COMPETITOR
CGON COMPARE
IBRX COMPARE
MRK COMPARE
RPRX COMPARE
URGN COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
BBC
0.15% · 37.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
79.28%
HOLDERS
79
TOP 12 OF 79 · RANKED BY POSITION SIZE
Fcpm Iii Services B.V.
9.6M sh · $65.79M
Perceptive Advisors LLC
5.9M sh · $53M
Siren, L.L.C.
5.3M sh · $35.77M
Vr Adviser, LLC
5.0M sh · $34.47M
Kynam Capital Management, LP
5.0M sh · $34.11M
Blue Owl Capital Holdings LP
4.4M sh · $30.08M
Deep Track Capital, LP
4.4M sh · $39.53M
Cormorant Asset Management, LP
4.0M sh · $36.12M
Braidwell LP
3.1M sh · $28.28M
Nextech Invest, Ltd.
2.3M sh · $15.83M
Vestal Point Capital, LP
2.2M sh · $14.74M
Janus Henderson Group Plc
1.9M sh · $17.11M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
OFFICER: SVP, FINANCE AND TREASURER
Richton Kathleen P.
— · 45.0K shares
2026-07-16
★
OFFICER: SVP, FINANCE AND TREASURER
Richton Kathleen P.
— · —
2026-07-16
★
OFFICER: SVP, FINANCE AND TREASURER
Richton Kathleen P.
— · 13.9K shares
2026-07-16
★
OFFICER: SVP, FINANCE AND TREASURER
Richton Kathleen P.
— · 105.0K shares
2026-07-16

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 3
UNDERWEIGHT 1
BUY 1
EQUAL WEIGHT 1
MARKET PERFORM 1
OUTPERFORM 1
8 GRADES IN THE LAST 12 MONTHS
Morgan Stanley UNDERWEIGHT HC Wainwright & Co. BUY UBS NEUTRAL Wells Fargo EQUAL WEIGHT Guggenheim NEUTRAL Piper Sandler NEUTRAL Citizens MARKET PERFORM Oppenheimer OUTPERFORM

SECTORS PEERS

PEERPRICE
ANRO$35.13COMPARE
ANNX$4.97COMPARE
SLN$13.42COMPARE
ALT$3.11COMPARE
LRMR$4.01COMPARE
CLLS$3.40COMPARE
DBVT$13.54COMPARE
AMRN$13.97COMPARE